SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The ticker is trending amid significant intraday volatility and a coordinated social media effort, with investors debating whether the price drop is an orchestrated shakeout of retail holdings or a reaction to the extended quiet period ahead of anticipated Phase 3 trial results. While bears express concerns over the lack of news and potential dilution, bulls remain focused on the clinical data and the potential for a transformative partnership or buyout.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble shares are trending following reports that Anthropic is the mystery customer behind a massive $13.7 billion six-year compute deal. While the announcement has energized investors regarding the company's AI cloud ambitions, the stock has faced volatility due to market-wide pressure on tech assets, concerns over potential dilution from warrants, and skepticism regarding the timeline for data center development.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending amid a broader sector rotation and volatility in semiconductor stocks, as traders debate the impact of slowing AI development calls and concerns over future AI infrastructure spending. Community sentiment remains polarized, with many retail traders actively day trading the volatility and positioning for sharp price swings.

The Elmet Group Co. engages in the provision of precision-engineered components. The firm offers its products and solutions to aerospace, defense, industrial, medical, semiconductor, electronics, energy industry and also the government. It operates through the Critical Materials Components and Engineered Microwave Products business divisions. The company was founded on September 13, 2024 and is headquartered in Portland, ME.

Elmet Group Co. (The)

The Elmet Group

The Elmet Group is trending due to a significant $450 million government investment and a $2 billion contract from the Defense Logistics Agency to bolster domestic tungsten supply. While many traders are bullish on the company's defense role and growth potential, others are debating whether parts of the financing package involve dilutive share offerings.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as traders react to Chairman Larry Ellison's surprise cancellation of a planned $7.5 billion stock sale, which has sparked bullish sentiment among retail investors hoping for a reversal. However, the stock faces downward pressure as the broader AI sector digests concerns over potential development slowdowns and high infrastructure capital expenditures.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The conversation surrounding semiconductors is dominated by concerns over the sustainability of AI infrastructure spending and the potential for a regulatory-driven slowdown in frontier AI development. Traders are debating whether these developments represent a long-term risk to chip demand or a temporary correction amidst ongoing market rotation between hardware and software sectors.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are trending as traders react to a broad semiconductor sell-off triggered by industry leaders calling for a slowdown in frontier AI development, though many in the community view the dip as a buying opportunity given the sustained long-term outlook for AI infrastructure spending. The debate remains polarized between those anticipating a major correction due to valuation concerns and those asserting that compute demand remains robust.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending following positive topline Phase 3 results from its Panorama study of DT120 for generalized anxiety disorder, with shares rising as investors react to the trial meeting all primary and key secondary endpoints. The community is focused on the company's clear path toward an NDA filing next year and its strong financial position, though some discussion remains regarding the long-term commercialization strategy for in-clinic administration.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to positive momentum following multiple breakthroughs in quantum computing and a multi-year partnership with Together AI to deploy advanced NVIDIA inference clusters on its cloud. Investors are responding to these developments as signs of a strategic recovery, fueling a debate between those viewing the recent price rebound as a sustainable reversal and others skeptical of the firm's long-term growth conversion.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron shares are facing volatility as traders debate the long-term impact of a widely publicized call from AI industry leaders to slow the development of frontier models. While some investors fear this could cool the demand for AI infrastructure and memory chips, many others maintain that the structural need for high-bandwidth memory remains robust and dismiss the selloff as a temporary market overreaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Newron Pharmaceuticals Spa.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

NWPHF News